These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2906007)

  • 1. Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative.
    MacDonald E; Scheinin H; Scheinin M
    Eur J Pharmacol; 1988 Dec; 158(1-2):119-27. PubMed ID: 2906007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute administration of medetomidine on the behaviour, temperature and turnover rates of brain biogenic amines in rodents and reversal of these effects by atipamezole.
    MacDonald E; Haapalinna A; Virtanen R; Lammintausta R
    Acta Vet Scand Suppl; 1989; 85():77-81. PubMed ID: 2571282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the behavioral and neurochemical effects of the two optical enantiomers of medetomidine, a selective alpha-2-adrenoceptor agonist.
    MacDonald E; Scheinin M; Scheinin H; Virtanen R
    J Pharmacol Exp Ther; 1991 Nov; 259(2):848-54. PubMed ID: 1682487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine.
    Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural and neurochemical effects of antipamezole, a novel alpha 2-adrenoceptor antagonist.
    Scheinin H; MacDonald E; Scheinin M
    Eur J Pharmacol; 1988 Jun; 151(1):35-42. PubMed ID: 2901363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced turnover of dopamine and 5-hydroxytryptamine in discrete dopaminergic, noradrenergic and serotonergic rat brain areas after acutely administered medetomidine, a selective alpha 2-adrenoceptor agonist.
    Koulu M; Pesonen U; Koskinen S; Scheinin H; Virtanen R; Scheinin M
    Pharmacol Toxicol; 1993 Mar; 72(3):182-7. PubMed ID: 8100065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profiles of medetomidine and its antagonist, atipamezole.
    Virtanen R
    Acta Vet Scand Suppl; 1989; 85():29-37. PubMed ID: 2571275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of medetomidine, an alpha 2-adrenoceptor agonist, in various pain tests.
    Pertovaara A; Kauppila T; Tukeva T
    Eur J Pharmacol; 1990 Apr; 179(3):323-8. PubMed ID: 1973106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.
    Rabin BC; Guo TZ; Gregg K; Maze M
    Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sex and age on brain monoamines and spatial learning in rats.
    Tanila H; Taira T; Piepponen TP; Honkanen A
    Neurobiol Aging; 1994; 15(6):733-41. PubMed ID: 7891829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of ethanol in combination with the alpha 2-adrenoceptor agonist dexmedetomidine and the alpha 2-adrenoceptor antagonist atipamezole on brain monoamine metabolites and motor performance of mice.
    Idänpään-Heikkilä JJ; Björn M; Seppälä T
    Eur J Pharmacol; 1995 Jan; 292(2):191-9. PubMed ID: 7536679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-2 adrenoceptor agonists decrease cyclic guanosine 3',5'-monophosphate in the mouse brain.
    Vulliemoz Y; Shen H; Virag L
    Anesthesiology; 1996 Sep; 85(3):544-50. PubMed ID: 8853084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
    Doze V; Chen BX; Li Z; Maze M
    Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sedative effects of medetomidine and its reversal by atipamezole in llamas.
    Waldridge BM; Lin HC; DeGraves FJ; Pugh DG
    J Am Vet Med Assoc; 1997 Dec; 211(12):1562-5. PubMed ID: 9412685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha 2-adrenergic drugs on the alcohol consumption of alcohol-preferring rats.
    Korpi ER
    Pharmacol Toxicol; 1990 Apr; 66(4):283-6. PubMed ID: 1973538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of alpha 2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats.
    Riekkinen P; Lammintausta R; Ekonsalo T; Sirviö J
    Eur J Pharmacol; 1993 Jul; 238(2-3):263-72. PubMed ID: 8104809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of medetomidine sedation in sheep by atipamezole and yohimbine.
    Mohammad FK; Zangana IK; Abdul-Latif AR
    Vet Hum Toxicol; 1995 Apr; 37(2):97-9. PubMed ID: 7631500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medetomidine--a novel alpha 2-adrenoceptor agonist: a review of its pharmacodynamic effects.
    Scheinin H; Virtanen R; MacDonald E; Lammintausta R; Scheinin M
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(5):635-51. PubMed ID: 2571177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats.
    Haapalinna A; MacDonald E; Viitamaa T; Salonen JS; Sirviö J; Virtanen R
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):194-203. PubMed ID: 10208306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of medetomidine sedation by atipamezole in pigs.
    Nishimura R; Kim H; Matsunaga S; Sakaguchi M; Sasaki N; Tamura H; Takeuchi A
    J Vet Med Sci; 1992 Dec; 54(6):1237-40. PubMed ID: 1362084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.